Farmakokinetiske populationsanalyser med data fra flere end 1300 RA patienter viste en tendens til en r ik
Population pharmacokinetic analyses with data from over 1300 RA patients revealed a trend toward higher apparent clearance of adalimumab with increasing body weight.